N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide
C22H31N5O4S — CID 121251051
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide
N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide (PubChem CID 121251051) has the molecular formula C22H31N5O4S and a molecular weight of 461.59 g/mol. Its IUPAC name is N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 121251051 |
| Molecular Formula | C22H31N5O4S |
| Molecular Weight | 461.59 g/mol |
| Exact Mass | 461.21 |
| IUPAC Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-tert-butyl-2-[4-(methoxymethyl)piperidin-1-yl]pyridine-3-carboxamide |
| SMILES | COCC1CCN(c2nc(C(C)(C)C)ccc2C(=O)NS(=O)(=O)c2cccc(N)n2)CC1 |
| InChI | InChI=1S/C22H31N5O4S/c1-22(2,3)17-9-8-16(20(24-17)27-12-10-15(11-13-27)14-31-4)21(28)26-32(29,30)19-7-5-6-18(23)25-19/h5-9,15H,10-14H2,1-4H3,(H2,23,25)(H,26,28) |
| InChIKey | UILKMDYSJQSFDY-UHFFFAOYSA-N |
| XLogP | 2.34 |
| TPSA | 127.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 461.59 |
| LogP ≤ 5 | 2.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121251051 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.